Skip to main content
BDSX
NASDAQ Life Sciences

Biodesix Q3 Revenue Misses Estimates by 13% as Net Loss Hits $8 Million

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$18.7
Mkt Cap
$209.334M
52W Low
$5.26
52W High
$31.97
52W Position info
256% above low
Off High info
42% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

BDSX has more than doubled off its 52-week low of $5.26.

Summary

Biodesix posted Q3 revenue of $24.041 million against an IBES estimate of $27.5 million, a shortfall of roughly 13%, with the company attributing the miss to seasonality impact and project delays. Operating expenses came in at $30.153 million, well above revenue, driving a net loss of $8.032 million for the quarter. The miss matters for a company of this size because the gap to consensus is wide and spending still outruns the top line. The prior timeline only shows insider buying by 10% owner Jack Schuler in August, which does not offset a revenue shortfall.

At the time of this announcement, BDSX was trading at $18.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $209.3M. The 52-week trading range was $5.26 to $31.97. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BDSX - Latest Insights

BDSX
Nov 12, 2026, 9:29 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $10.12
Real-time Price: $7.56 info
Change: -$2.56 (-25%) info
Market Cap: $83.829M info
BDSX
Nov 12, 2026, 9:29 AM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $10.12
Real-time Price: $7.56 info
Change: -$2.56 (-25%) info
Market Cap: $83.829M info
BDSX
Nov 06, 2026, 3:24 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $7.56 info
Change: -$4.05 (-35%) info
Market Cap: $83.829M info
BDSX
Nov 05, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.00
Real-time Price: $7.56 info
Change: -$8.44 (-53%) info
Market Cap: $83.829M info
BDSX
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $7.56 info
Change: -$11.14 (-60%) info
Market Cap: $83.829M info